Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828412 · ClinicalTrials.gov registry record · Phase 4
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
A Phase 4 study, sponsored by Promius Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00828412 is a Phase 4 study that has completed, run by Promius Pharma. The registered enrollment target is 100 participants.
The verdict
NCT00828412, a Phase 4 study, has completed, sponsored by Promius Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.
Interventions
- DEVICE EpiCeram Skin Barrier Emulsion
- DRUG Desonide Cream 0.05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828412
The ClinicalTrials.gov registry entry for NCT00828412 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Promius Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EpiCeram Skin Barrier Emulsion is the first listed.
NCT00828412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00828412 about?
NCT00828412 is a clinical study titled "Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis". This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.
What is the current status of trial NCT00828412?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2009-03. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00828412?
The interventions under investigation include: EpiCeram Skin Barrier Emulsion (DEVICE), Desonide Cream 0.05% (DRUG).
Who is sponsoring clinical trial NCT00828412?
This trial is sponsored by Promius Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.